NASDAQ · SEER

Seer, Inc.

$1.97 -$0.08 (-3.90%) 1D After hours

Key Metrics

$108.31M
Market cap
34.82×
P/E · TTM
−$1.41M
Revenue · TTM
$3.11M
Net income
EPS · TTM $0.06
Dividend yield
Free cash flow
Beta · 1Y 1.00
EBITDA · TTM
Gross margin 76.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 20
    A material event was filed (Form 8-K).

    8-K - Seer, Inc. (0001726445) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 6
    The stock moved +35.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 6
  • Feb 27
    The stock moved -17.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 27

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$108.31M
Enterprise value
Shares outstanding55.0M
52-wk range$1.55 – $2.41
Avg volume · 20D393.2K
Net cash
Book value / share$4.39
IndustryLaboratory Analytical Instruments
ExchangeNASDAQ
About Seer, Inc.
IPO dateDec 4, 2020
Employees124

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E34.82
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №$2.36

Profitability

Gross 76.4%
Operating -246.1%
Net -220.3%
FCF
ROE / ROIC 1.3% · —

Financial Health

Current ratio17.73
Quick ratio16.94
Debt / equity
Debt / EBITDA
Net cash
Working capital$171.35M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

0.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$2.36 vs $1.97
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings